FCBA Weighs In On Recusal In Myriad Gene Patent Suit
Without endorsing either side, the Federal Circuit Bar Association has weighed in on a bid by plaintiffs fighting the patentability of human genetic material to exclude a judge, based on remarks...To view the full article, register now.
Already a subscriber? Click here to view full article